[The non-recommendations in the treatment of osteoarthritis and rheumatoid arthritis, or why is evidence-based medicine so difficult (still) to apply to rheumatology?].
The speed with which the phrase "Evidence-Based Medicine" has entered our language has been astonishing. Virtually all medical areas are concerned, but it probably applies best when clearcut diagnosis can be made or when mortality or well-defined morbidity are the outcomes, two conditions not really frequently encountered in rheumatology. We will discuss why rheumatology is probably not ready yet for the concept and will systematically review why "Evidence-Based Medicine" could in fact be "evidence-biased medicine". We will emphasize why evidence-based medicine can not replace the personal experience and knowledge of patients, two major corner-stones in the clinician's daily work, but should simply be an access to scientific data for the benefit of both patient and physician.
Malaise
M G
MG
Département de Médecine Interne, Université de Liège.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003657:Decision Making; D019317:Evidence-Based Medicine; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic